The ERC-StG Grant BioEle is at the forefront of pioneering a technology that revolutionizes the creation of functional biointerface fibres through direct-writing solution processing. This innovation is synergistically integrated with 3D bioprinting, culminating in a comprehensive multiscale biofabrication platform. The BioELE initiative has yielded various discoveries, culminating in contributions to peer-reviewed journals such as Nature Materials, Science Advances, Nature Communications, and Advanced Science. Beyond the advancements in 'fiber printing' technology, our team has engineered novel eco-friendly fiber formats that boast diverse form factors, and advanced sensing capabilities. Among these, select fibers emerge as frontrunners, exhibiting potential for commercial viability.
The associated technology has led to a patent application. This patent encompasses the fiber printing technology, the proprietary ink formulation, and the subsequent yarn production process. In parallel, we have amassed a wealth of commercially pertinent expertise pertaining to the manufacturing techniques, which is poised for licensing to industrial producers. The commercialization prospects of this intellectual property are vast, with potential applications spanning from health diagnostics to in vitro models, and extending to electronic textiles. These applications are not only viable but also align with real-world industrial needs, offering a solid foundation for market analysis and strategy development.
The outcomes of the BioELE project have been disseminated across the academic sphere via various conferences. Furthermore, the project's achievements have captured the attention of the broader public, thanks to coverage by different national and international media platforms, thereby enhancing public engagement and awareness of this cutting-edge research.
